Polymorphonuclear leukocyte integrins in deep venous thrombosis by Caimi, G. et al.
ClinAppl Thrombosis/Hemostasis ll(l):95-97, 2005
©2005 Westminster Publications, Inc., Glen Head, NY
Polymorphonuclear Leukocyte Integrins
in Deep Venous Thrombosis
G. Caimi, MD, B. Canino, MD, F. Ferrara, MD, M. Montana, ScD, and R. Lo Presti, MD
Department of Internal Medicine, Cardiovascular and Renal Diseases, Universitci di Palermo, Palermo, Italy
Summary: The polymorphonuclear leukocytes (PMN) have a role in
the pathophysiology of deep venous thrombosis (DVT). We exam-
ined the phenotypical expression of PMN beta^-integrins (CD 11 a,
CDl 1 b, CD I k ) in a group of 19 subjects with leg DVT. PMN cells
were incubated with fluorescent monoclonal antibodies against
CDlla, CDllb, CDllc, and the evaluation v̂ ras made by flow cyto-
fluorimetry. The same integrins were determined after in vitro acti-
vation with 4-phorbol 12-myristate 13-acetate (PMA) and N-formyl-
methionyl-leucyl-phenylalanine (fMLP). In DVT subjects, at baseline.
the phenotypical expression of CDllb was decreased and that of
CDllc increased when compared with normal controls. In normal
subjects PMN activation with PMA and fMLP led to a constant in-
crease of all PMN adhesion molecules, while in DVT subjects the CDl
1 a did not show any change. These data might have therapeutical ap-
plications, especially with the aim of preventing post-thrombotic de-
terioration of vein function.
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Several papers (1-5) have underlined the role
of leukocj^es in deep venous thrombosis (DVT).
During thrombogenesis in deep veins, an inflam-
matory response develops, and both processes in-
volve complex interactions between circulating
cells and vessel wall, primarily endothelial cells.
The initial reversible interaction between circu-
lating leukocytes and endothelium is mediated
by L-selectin (constitutively present on non-acti-
vated leukocytes) and endothelial E-selectin,
while firm polymorphonuclear leukocyte (PMN)
adhesion to the endothelial surface and their
subsequent transendothelial migration require
PMN expression of p^-integrins, that increases
after cell activation. Cell activation is stimulated
by thrombin itself and by a local production of
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pro-inflammatory cytokines (tumor necrosis fac-
tor-a [TNF-a], interleukin-6, etc.) that establish
a chemotactic gradient toward the vein wall.
In animal models of venous thrombosis (6,7),
a partial inhibition of leukocj^e infiltration in the
vein wall has been obtained through immuniza-
tion against TNF-a, P^-integrins (CD 18), inter-
cellular adhesion molecule-1 (ICAM-1), and P-
selectin. The latter, expressed by activated
platelets and endothelium, seems to have an es-
sential role in the interrelated processes of
thrombosis and inflammation. Its inhibition, in
animal venous thrombosis, induced a decrease of
leukocyte infiltration in the vein wall and a re-
duced collagen synthesis (8,9).
Clinical studies suggest that in human DVT
there is a similar involvement of inflammatory
cells and mediators (10,11), and some adhesion
molecules have been proposed as markers of
thrombosis onset in patients at high risk (12).
We previously examined, in DVT subjects, the
behavior of some parameters reflecting the func-
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tional activity of the PMNs (membrane fluidity
and cj^osolic Ca2+ content), before and after in
vitro activation with 4-phorbol 12-myristate 13-
acetate (PMA) and N-formyl-methionyl-leucyl-
phenylalanine (fMLP), demonstrating a systemic
PMN functional abnormality (13). To our knov\̂ l-
edge, there are few studies concerning the PMN
integrin profile in venous diseases (14).
Our group recently determined, in 19 subjects
(11 men and 8 women; mean age 59.4 ± 15.8
years) with acute leg DVT, demonstrated by
echo-color-Doppler, the PMN integrin pattern
(CDlla, CDllb, CDllc) obtained by using a
flow cytofluorimetry (FACscan, Becton
Dickinson) before and after activation (pro-
longed for 15 minutes) with PMA and fMLP.
Venous blood samples were drawn from the arm
of each subject within 3 days from diagnosis.
In DVT subjects, at baseline, the phenotypical
expression of CDllb was decreased and that of
CDllc was increased in comparison with normal
controls; no difference was found in CDlla ex-
pression (Table 1). PMN activation with PMA
and fMLP led to a constant and significant in-
crease of CDlla, CDllb, and CDllc in normal
subjects while in DVT subjects only an increase of
CDllb and CDllc was observed with both
agents (Table 1).
While the baseline decrease of CDllb ob-
served in DVT subjects might depend on its con-
sumption, the baseline increase of CDllc might
be correlated to a spontaneous PMN activation.
In DVT subjects after activation only the expres-
sion of CDllb and CDllc showed a trend similar
to that found in normal subjects while CDlla,
constitutively expressed on the PMN surface, did
not show any change.
Although these results are preliminary, we
think that the PMN integrin expression in DVT
deserves attention, considering tbat in the fu-
ture the therapeutic use of specific antibodies
directed toward PMN integrins, with the aim of
attenuating inflammation in the vein wall,
might favorably influence the clinical outcome
of the disease and prevent the deterioration of
vein function (4).
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TABLE 1. Means ± S.D. of the PMN Adhesion Molecules in Normal Subjects and in DVT Subjects,































+p < 0.001 vs normal subjects.
*p < 0.05.
5p < 0.001 vs baseline.
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